chapter 1
DESCRIPTION
TRANSCRIPT
MLAB 1415: HematologyMLAB 1415: HematologyKeri Brophy-MartinezKeri Brophy-Martinez
Chapter 11:Thalassemia
1
Overview Overview Diverse group of congenital disorders which
manifest as anemia of varying degrees.
Result of quantitative defective production of one or more globin portion(s) of hemoglobin molecule.
The decreased globin production causes◦ Imbalanced globin chain synthesis◦ Defective hemoglobin production◦ Damage to the RBC
Distribution is worldwide.
2
Thalassemia Thalassemia
Results in overall decrease in amount of hemoglobin produced and may induce hemolysis.
Two major types of thalassemia: ◦Alpha (α) - Caused by defect in rate
of synthesis of alpha chains. ◦Beta (β) - Caused by defect in rate of
synthesis in beta chains. May contribute protection against
malaria. 3
Genetics of ThalassemiaGenetics of Thalassemia
May be either homozygous defect or heterozygous defect.
Genetic defects usually falls into one of below categories◦Gene deletion◦Promoter deletion◦Nonsence mutation◦Mutated termination◦Splice site mutation
4
Review of Hgb StructureReview of Hgb StructureNormal globin genes
◦ Alpha, beta, delta, gamma Form hgb A (97%), hgb A2(2-3%), hgb F (2%)
◦ Epsilon, zeta: in utero◦ Gamma: 3rd trimester until birth◦ Adult hemoglobin composed two alpha and two
beta chains.
Thalassemia causes an excess of one of these chains
5
PathophysiologyPathophysiologyα-chain excess
unstablePrecipitates within the cell, causes damageMacrophages destroy the damaged RBCs in
the bone marrow, leads to ineffective erythropoiesis
Spleen also removes damaged RBCs, leads to chronic extravascular hemolysis
6
Pathophysiology con’tPathophysiology con’tβ-chain excess◦ Unstable◦ Combines to form hgb molecules with 4 β-
chains ( hemoglobin H) Infants: excess gamma chains combine with hgb molecules (hemoglobin Bart’s)
◦ High oxygen affinity, poor transporter of oxygen
7
Clinical and Laboratory Findings Associated with ThalassemiaClinical and Laboratory Findings Associated with Thalassemia
Clinical FindingsClinical Findings
9
Comparison of Comparison of Hemoglobinopathies and Hemoglobinopathies and ThalassemiasThalassemias
Disease RBC count
Indices RBC Morph Abnormal Hb
Ancestry Retic Count
Hemoglobinopathy
Normocytic
Normochromic
Target cells, sickle cells (HbS),Crystals (HbC)
HbS,HbC, HbE etc
AfricanMediterraneanMiddle EasternAsian
Thalassemia Microcytic
Hypochromic
Target cells, basophilic stippling
HbHHb Bart’s
AfricanMediterraneanAsian
10
Thalassemia: globin chains structurally normalHemoglobinopathies: globin chain is abnormal
Beta Beta ThalassemiaThalassemia
11
Classical Syndromes of Beta Classical Syndromes of Beta ThalassemiaThalassemiaBeta thalassemia minima/
Silent carrier state – the mildest form of beta thalassemia.
Beta thalassemia minor - heterozygous disorder resulting in mild hypochromic, microcytic hemolytic anemia.
Beta thalassemia intermedia - Severity lies between the minor and major.
Beta thalassemia major - homozygous disorder resulting in severe transfusion-dependent hemolytic anemia. 12
Beta Thalassemia Minor Beta Thalassemia Minor
Caused by heterogenous mutations that affect beta globin synthesis.
Usually presents as mild, asymptomatic hemolytic anemia unless patient in under stress such as pregnancy, infection, or folic acid deficiency.
Have one normal beta gene and one mutated beta gene.
13
Beta Thalassemia Minor Beta Thalassemia Minor
Anemia usually mildRarely see hepatomegaly or
splenomegaly. Have high Hb A2 levels (3.5-8.0%) and
normal to slightly elevated Hb F levels.
Are different variations of this form depending upon which gene has mutated.
Normally require no treatment. Make sure are not diagnosed with iron
deficiency anemia. 14
FIGURE 11-11 Patients with FIGURE 11-11 Patients with ββ-thalassemia minor show minimal morphologic abnormalities to include microcytosis -thalassemia minor show minimal morphologic abnormalities to include microcytosis with target cells. The CBC in this patient showed the following results: Hb 11.1 g/dL; RBC count 5.2 x 10with target cells. The CBC in this patient showed the following results: Hb 11.1 g/dL; RBC count 5.2 x 10 1212/L; MCV 61 /L; MCV 61 fL; MCH 20.2 pg; MCHC 33 g/L. (Wright-Giemsa stain; 1000x magnification)fL; MCH 20.2 pg; MCHC 33 g/L. (Wright-Giemsa stain; 1000x magnification)
ββ-thal Minor – microcytic, occ -thal Minor – microcytic, occ codocyte, basophilic stippling codocyte, basophilic stippling
Beta Thalassemia Major/ Beta Thalassemia Major/ Cooley’s anemia Cooley’s anemia
Severe microcytic, hypochromic anemia. ◦ Severe anemia causes marked bone
changes due to expansion of marrow space for increased erythropoiesis.
◦ See characteristic changes in skull, long bones, and hand bones
Detected early in childhood
Hb A production is reducedHbA2 and Hg F production increased
17
Clinical Findings:Clinical Findings:ββ-Thalassemia Major-Thalassemia MajorInfants
◦Irritability, pallor, failure to thrive◦Diarrhea, fever, enlarged abdomen
Severe anemiaCardiac failureBronze pigmentation of skinBone changes
◦Bossing of skull, facial deformities, “hair-on-end” appearance of skull
Hepatosplenomegaly
FIGURE 11-8 Increased erythropoiesis in the bone marrow of patients with FIGURE 11-8 Increased erythropoiesis in the bone marrow of patients with ββ-thalassemia major expands the marrow cavity -thalassemia major expands the marrow cavity producing the typical “hair-on-end” appearance as seen on this radiograph of the skull of a boy with producing the typical “hair-on-end” appearance as seen on this radiograph of the skull of a boy with ββ-thalassemia.-thalassemia.
Laboratory Findings:Laboratory Findings:ββ-Thalassemia Major-Thalassemia Major
Hb can be as low as 2–3 g/dLMicrocytic hypochromic
◦MCV < 67 fL, ↓ MCH and MCHCPeripheral blood smear
◦Anisocytosis and poikilocytosis◦Basophilic stippling, polychromasia◦NRBCs◦↑ RDW
FIGURE 11-9 Peripheral blood smear from a patient with FIGURE 11-9 Peripheral blood smear from a patient with ββ-thalassemia major showing marked anisopoikilocytosis. -thalassemia major showing marked anisopoikilocytosis. Target cells, schistocytes, teardrops, and ovalocytes are the major poikilocytes observed. An NRBC is also present. Target cells, schistocytes, teardrops, and ovalocytes are the major poikilocytes observed. An NRBC is also present. (1000x magnification; Wright-Giemsa stain)(1000x magnification; Wright-Giemsa stain)
ββ-Thalassemia Major-Thalassemia MajorTreatment
◦Regular transfusions Minimize anemia Reduce excess iron absorption Suppress ineffective erythropoiesis
◦Iron-chelating agents◦Splenectomy
Prognosis◦Untreated – die during 1st or 2nd
decade◦Hypertransfusion with iron chelation
Extend for ≥ 1 decade
Hereditary Persistence of Fetal Hereditary Persistence of Fetal Hemoglobin (HPFH) Hemoglobin (HPFH)
Rare condition characterized by continued synthesis of Hemoglobin F in adult life.
Do not have usual clinical symptoms of thalassemia.
Kleihauer-Betke stain useful tool to identify
23